Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Core Scientific (CORZ) Equity Ratio (2020 - 2025)

Core Scientific's Equity Ratio history spans 6 years, with the latest figure at 0.52 for Q3 2025.

  • For Q3 2025, Equity Ratio rose 48.18% year-over-year to 0.52; the TTM value through Sep 2025 reached 0.52, up 48.18%, while the annual FY2024 figure was 0.56, 33.7% up from the prior year.
  • Equity Ratio for Q3 2025 was 0.52 at Core Scientific, down from 0.21 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.55 in Q4 2021 and bottomed at 1.78 in Q2 2024.
  • The 5-year median for Equity Ratio is 0.45 (2022), against an average of 0.32.
  • The largest annual shift saw Equity Ratio skyrocketed 135.38% in 2022 before it tumbled 1241.14% in 2023.
  • A 5-year view of Equity Ratio shows it stood at 0.55 in 2021, then crashed by 192.16% to 0.51 in 2022, then plummeted by 65.39% to 0.84 in 2023, then soared by 33.7% to 0.56 in 2024, then rose by 6.52% to 0.52 in 2025.
  • Per Business Quant, the three most recent readings for CORZ's Equity Ratio are 0.52 (Q3 2025), 0.21 (Q1 2025), and 0.56 (Q4 2024).